Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jun;14(6):333-342.
doi: 10.1038/nrgastro.2017.33. Epub 2017 Apr 12.

Molecular subtypes in cancers of the gastrointestinal tract

Affiliations
Review

Molecular subtypes in cancers of the gastrointestinal tract

Maarten F Bijlsma et al. Nat Rev Gastroenterol Hepatol. 2017 Jun.

Abstract

Malignancies of the gastrointestinal tract are among the most common human cancers. The distinct tissues of origin give rise to a diverse set of diseases, such as colorectal cancer, pancreatic carcinoma and gastric cancers, with each associating with specific clinical features. Genomic and transcriptomic analyses have further defined the heterogeneity that occurs within these cancers by identifying so-called molecular subtypes. These subtypes are characterized by specific genetic aberrations and expression signatures that suggest important biological differences. Although at first sight this subdivision of organ-specific cancers might increase the complexity of classification, closer analysis suggests that the subtypes detected in the various malignancies are recurring. For example, nearly all gastrointestinal cancers appear to present with subtypes that are either characterized by a mesenchymal gene expression signatures, extensive immune infiltration or metabolic dysregulation. Additionally, in each of the gastrointestinal malignancies, a 'canonical' subtype is recognized that retains characteristic features of the epithelial tissue of origin. These common themes can enhance our collective understanding of these malignancies, and could perhaps be therapeutically exploited. In this Review, the identification of subtypes in the various gastrointestinal cancer types are discussed along with how they could be incorporated into clinical practice.

PubMed Disclaimer

References

    1. Nature. 2017 Jan 12;541(7636):169-175 - PubMed
    1. Surg Oncol. 2015 Jun;24(2):61-6 - PubMed
    1. Clin Cancer Res. 2012 Nov 15;18(22):6339-47 - PubMed
    1. Gastroenterology. 2015 Oct;149(5):1226-1239.e4 - PubMed
    1. N Engl J Med. 2011 Feb 10;364(6):501-13 - PubMed

MeSH terms